Company intelligence / Profile preview
Ergon Pharmaceuticals
- Ownership
- Private
- Employees
- ~65
- Development stage
- Commercial
Overview
Ergon Pharmaceuticals operates as a producer of Ayurvedic/herbal medicines with a broad commercial product line targeting common chronic and acute conditions. A separate US-based entity appears to be engaged in preclinical/translational research into B-cell metabolism as therapeutic targets for cancer and autoimmune diseases.
- Therapeutic areas
- Men's HealthMetabolic DisordersPulmonologyEndocrinologyRheumatologyGastroenterologyCardiovascularInfectious Diseases
- Modalities
- Herbal/Ayurvedic formulationsSmall molecules (inferred from drug pipeline context for LLC entity)
- Industry
- Biotech
Drug pipeline
15 assets14 more assets in the full pipeline.
Beyond the preview
Go deeper on Ergon Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ergon Pharmaceuticals.